FDA approves Aclaris’ treatment for a common skin condition
The treatment, called Eskata, is the first topical medicine for a type of noncancerous skin growth that affects more than 83 million American adults, and represents Aclaris' first product.
The hydrogen peroxide solution, which is administered in a pen-type applicator in a physician's office, dissolves the growths.
Current treatments are cryosurgery or freezing, burning, cutting, or scraping the growths off, all more invasive and potentially painful options, the company said.
Eskata is expected to be available to dermatologists and healthcare providers in April or May for
The condition is more prevalent than acne, psoriasis and rosacea combined, the company said. The growths often appear on the face, chest, shoulders, or back and have a waxy, scaly, slightly elevated appearance that can vary in color from light tan to dark brown or black.
"They are completely benign, but patients don't like them because they are discolored and have a three-dimensional component and so they seek removal because of the appearance," Walker said.
Health insurance will not cover the treatment. Most growths do not require removal unless a biopsy is needed, the growth has become inflamed, or a patient desires treatment for cosmetic reasons, the company said.
Aclaris, which has 100 employees and plans to hire a sales force of 50, is developing dermatology treatments that are in mid-stage studies for common warts, hair loss, and Vitiligo, which is skin pigment loss.
Walker was president and CEO of another company focused on dermatology, Vicept Therapeutics in Malvern, which was acquired by
"For the first time, with the approval of Eskata, patients will have access to an
Aclaris shares closed down 1.98 percent, or
___
(c)2017 Philly.com
Visit Philly.com at www.philly.com
Distributed by Tribune Content Agency, LLC.
Judge sets Mohegan Sun tax assessment — $152.2M
Many Illinois consumers still have time to buy Obamacare plans under little-discussed exception
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News